McLeod H - Search Results

1

Pharmacogenomics, ancestry and clinical decision making for global populations.

Ramos E, Doumatey A, Elkahloun AG, Shriner D, Huang H, Chen G, Zhou J, McLeod H, Adeyemo A, Rotimi CN. Ramos E, et al. Among authors: mcleod h. Pharmacogenomics J. 2014 Jun;14(3):217-22. doi: 10.1038/tpj.2013.24. Epub 2013 Jul 9. Pharmacogenomics J. 2014. PMID: 23835662

2

The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics.

McLeod HL, Siva C. McLeod HL, et al. Pharmacogenomics. 2002 Jan;3(1):89-98. doi: 10.1517/14622416.3.1.89. Pharmacogenomics. 2002. PMID: 11966406 Review.

3

Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway.

Fukunaga AK, Marsh S, Murry DJ, Hurley TD, McLeod HL. Fukunaga AK, et al. Among authors: mcleod hl. Pharmacogenomics J. 2004;4(5):307-14. doi: 10.1038/sj.tpj.6500259. Pharmacogenomics J. 2004. PMID: 15224082

4

Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

Ferrell PB Jr, McLeod HL. Ferrell PB Jr, et al. Pharmacogenomics. 2008 Oct;9(10):1543-6. doi: 10.2217/14622416.9.10.1543. Pharmacogenomics. 2008. PMID: 18855540 Free PMC article.

5

Race does not explain genetic heterogeneity in pharmacogenomic pathways.

Yen-Revollo JL, Auman JT, McLeod HL. Yen-Revollo JL, et al. Pharmacogenomics. 2008 Nov;9(11):1639-45. doi: 10.2217/14622416.9.11.1639. Pharmacogenomics. 2008. PMID: 19018720 Free PMC article.

6

Influence of ethnicity on pharmacogenetic variation in the Ghanaian population.

Yen-Revollo JL, Van Booven DJ, Peters EJ, Hoskins JM, Engen RM, Kannall HD, Ofori-Adjei D, McLeod HL, Marsh S. Yen-Revollo JL, et al. Among authors: mcleod hl. Pharmacogenomics J. 2009 Dec;9(6):373-9. doi: 10.1038/tpj.2009.28. Epub 2009 Jun 23. Pharmacogenomics J. 2009. PMID: 19546880

7

Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan.

Hoskins JM, Rosner GL, Ratain MJ, McLeod HL, Innocenti F. Hoskins JM, et al. Pharmacogenomics. 2009 Jul;10(7):1139-46. doi: 10.2217/pgs.09.35. Pharmacogenomics. 2009. PMID: 19604089 Free PMC article.

8

Using germline genotype in cancer pharmacogenetic studies.

McWhinney SR, McLeod HL. McWhinney SR, et al. Pharmacogenomics. 2009 Mar;10(3):489-93. doi: 10.2217/14622416.10.3.489. Pharmacogenomics. 2009. PMID: 19650256 Free PMC article. Review.

9

Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations.

Ellis KJ, Stouffer GA, McLeod HL, Lee CR. Ellis KJ, et al. Pharmacogenomics. 2009 Nov;10(11):1799-817. doi: 10.2217/pgs.09.143. Pharmacogenomics. 2009. PMID: 19891556 Review.

10

Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care.

Rakhra-Burris TK, Auman JT, Deverka P, Dressler LG, Evans JP, Goldberg RM, Havener TM, Hoskins JM, Jonas DE, Long KM, Motsinger-Reif AA, Irvin WJ, Richards KL, Roederer MW, Valgus JM, Riper Mv, Vernon JA, Zamboni WC, Wagner MJ, Walko CM, Weck KE, Wiltshire T, McLeod HL. Rakhra-Burris TK, et al. Pharmacogenomics. 2010 Jan;11(1):13-21. doi: 10.2217/pgs.09.167. Pharmacogenomics. 2010. PMID: 20017668 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

763 results

Search Page